The fatal shooting of UnitedHealth chief executive Brian Thompson in New York was initially greeted by markets as an isolated tragedy.
That has changed, with shares subsequently diving as investors digested the public’s growing anger towards the healthcare giant.
Luigi Mangione, the suspect in the case, saw his X account explode from a few hundred followers to more than 420,000. Scrutiny about US healthcare practices grew after it emerged the bullets used in the killing were marked with the words “delay”, “deny” and “depose”.
Social media lit up with stories of denied insurance claims and accusations that UnitedHealth cares more about its bottom line than patients’ wellbeing. Various high-profile politicians are calling for reform of the system, and investors are clearly worried about a regulatory backlash.
Developing hydrogen fuel could achieve energy security in transport for Ireland
EU needs to step up financing to support collective security and accelerate productivity and growth
Mario Rosenstock: ‘Everyone lost money in the crash. I was no different, but it never bothered me’
UnitedHealth targeted: US healthcare giant faces scrutiny after chief executive’s murder
As Columbia economist Prof Laura Veldkamp cautioned, an excessive focus on shareholder value over customers can create its own risks. The falling share price, she suggested, “will help convey to shareholders that they too will lose if stakeholders aren’t taken into account”.
- Sign up for Business push alerts and have the best news, analysis and comment delivered directly to your phone
- Find The Irish Times on WhatsApp and stay up to date
- Our Inside Business podcast is published weekly – Find the latest episode here
